(Q40307292)

19 September 2017

1 reference

title

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs (English)

1 reference

19 September 2017

1 reference

L Balant

1

1 reference

19 September 2017

1 May 1981

1 reference

Clinical Pharmacokinetics

19 September 2017

1 reference

19 September 2017

6

1 reference

19 September 2017

3

1 reference

19 September 2017

215-241

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198106030-00003

19 September 2017

0 references

cites work

Drug interactions and long-term antidiabetic therapy

1 reference

12 December 2020

Tolbutamide binding to plasma proteins of young and old human subjects

1 reference

12 December 2020

Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)

1 reference

12 December 2020

[Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man]

1 reference

12 December 2020

The pancreatic -cell recognition of insulin secretagogues. IV. Islet uptake of sulfonylureas.

1 reference

12 December 2020

[Hypoglycemic coma due to antidiabetic sulfonamides. Apropos of 16 cases]

1 reference

12 December 2020

Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus

1 reference

12 December 2020

Insulin secretion: multifactorial regulation for a single process of release. The Minkowski award lecture delivered on September 7, 1972 before the European Association for the study of Diabetes at Madrid, Spain

1 reference

12 December 2020

Binding of Sulfonylureas to Serum Albumin

1 reference

12 December 2020

Pharmacokinetics of tolbutamide: prediction by concentration in saliva

1 reference

12 December 2020

Half-life of tolbutamide in patients with chronic respiratory failure

1 reference

12 December 2020

The physical properties of chlorpropamide and its determination in human serum

1 reference

12 December 2020

Des 4-trans-hydroxy-glibenclamide show hypoglycemic activity?

1 reference

12 December 2020

Gas chromatographic procedure for the simultaneous determination of five common antidiabetic drugs in blood

1 reference

12 December 2020

INCREASE IN DRUG OXIDIZING ENZYME ACTIVITY WITH TOLBUTAMIDE

1 reference

12 December 2020

A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas

1 reference

12 December 2020

[The possibility of colorimetric determination of N-(4-methyl-benzolsulfonyl)-N'-butyl urea in blood]

1 reference

12 December 2020

Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide

1 reference

12 December 2020

METABOLISM OF ANTIDIABETIC SULFONYLUREAS IN MAN. I. BIOLOGICAL HALF-LIVES OF THE P-ACETYLBENZENESULFONYLUREAS, U-18536 AND ACETOHEXAMIDE AND THEIR METABOLITES

1 reference

12 December 2020

Carbohydrate metabolism in uremia: blood glucose response to sulfonylurea

1 reference

12 December 2020

Binding of Sulfonylureas to Serum Proteins

1 reference

12 December 2020

The use of solid probe chemical ionization mass spectrometry and gas chromatography-chemical ionization mass spectrometry in quantitation of drugs in biological fluids. Determination of tolbutamide and its metabolites in human plasma

1 reference

12 December 2020

Measurement of plasma concentrations of tolbutamide by simplified gas-liquid chromatography

1 reference

12 December 2020

Control of the blood glucose in diabetes mellitus is it valuable? Is it feasible

1 reference

12 December 2020

"First" and "second" generation sulfonylureas: distinction or difference? (author's transl)

1 reference

12 December 2020

Pharmacology and mode of action of the sulphonylureas in man

1 reference

12 December 2020

[Glucose and HB 419-concentration in blood as well as HB 419-excretion in urine after single oral application of HB 419-14C]

1 reference

12 December 2020

Complex formation between macromolecules and drugs. X. Binding of tolbutamide, chlorpropamide and carbutamide to human serum albumin, and the competition between tolbutamide or chlorpropamide and carbutamide or 4-sulfanilamido-2,6-dimethylpyrimidine

1 reference

12 December 2020

Behaviour of glibenclamide on repeated administration to diabetic patients

1 reference

12 December 2020

Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function

1 reference

12 December 2020

Glucoreceptor mechanisms and the control of insulin release and biosynthesis

1 reference

12 December 2020

Drug absorption, metabolism, and excretion. IX. Some new aspects of pharmacokinetics on tolbutamide in rabbits

1 reference

12 December 2020

Diabetes: The genetic connections

1 reference

12 December 2020

Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents

1 reference

12 December 2020

Fluorometric determination of glibornuride in plasma and serum using 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole

1 reference

12 December 2020

Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients

1 reference

12 December 2020

[Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man]

1 reference

12 December 2020

GC Determination of Tolazamide in Plasma

1 reference

12 December 2020

Determination of sulfonylureas and metabolites by pyrolysis gas chromatography

1 reference

12 December 2020

Gas chromatographic and mass spectral properties of sulfonylurea N-methyl-N'-perfluoroacyl derivatives

1 reference

12 December 2020

A method for the routine determination of chlorpropamide in plasma

1 reference

12 December 2020

[Tolbutamide metabolism in kidney failure]

1 reference

12 December 2020

Binding of four sulphonamides to human albumin

1 reference

12 December 2020

Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose

1 reference

12 December 2020

A method for radioimmunological assay of glisoxepide (author's transl)

1 reference

12 December 2020

Chlorpropamide-Induced Water Retention in Patients with Diabetes Mellitus

1 reference

12 December 2020

Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration

1 reference

12 December 2020

The nature of the metabolites of acetohexamide in the rat and in the human

1 reference

12 December 2020

Metabolic fate of chlorpropamide in man

1 reference

12 December 2020

The comparative pharmacology of tolbutamide, carbutamide, chlorpropamide and metahexamide in man

1 reference

12 December 2020

14C-Glibenclamide concentrations in serum and 14C-glibenclamide urine excretion in diabetic patients with simultaneous determination of blood glucose and insulin (author's transl)

1 reference

12 December 2020

The radioimmunological determination of glibenclamide and its metabolites in serum

1 reference

12 December 2020

[Physico-chemical and analytical studies on HB 419]

1 reference

12 December 2020

DISAPPEARANCE RATE OF TOLBUTAMIDE IN NORMAL SUBJECTS AND IN DIABETES MELLITUS, LIVER CIRRHOSIS, AND RENAL DISEASE

1 reference

12 December 2020

Metabolism and relative hypoglycemic potencies of four sulfonylureas in man

1 reference

12 December 2020

Spectrophotometric determination of tolbutamide in plasma

1 reference

12 December 2020

Metabolism of glibornuride in the human

1 reference

12 December 2020

Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases

1 reference

12 December 2020

88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969

1 reference

12 December 2020

RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTION

1 reference

12 December 2020

Spontaneous hypoglycemia in diabetic patients with renal insuff- iciency

1 reference

12 December 2020

A study of the metabolic fate of chlorpropamide in man

1 reference

12 December 2020

SERUM CONCENTRATION AND URINARY EXCRETION OF ORAL SULFONYLUREA COMPOUNDS: RELATION TO DIABETIC CONTROL

1 reference

12 December 2020

Sulphonylureas increase the number of insulin receptors

1 reference

12 December 2020

Comparative Pharmacokinetics of Coumarin Anticoagulants XXXVII: Simultaneous In Vivo Displacement of Dicumarol from Serum Protein and Tissue Binding Sites by Tolbutamide in Rats

1 reference

12 December 2020

Comparison of the pharmacokinetics of glipizide and glibenclamide in man

1 reference

12 December 2020

Plasma insulin and metabolic study on diabetes treated with glibenclamide

1 reference

12 December 2020

Studies on the bioavailability of glibenclamide

1 reference

12 December 2020

The metabolic fate of tolbutamide in man and in the rat

1 reference

12 December 2020

Prolonged hypoglycemia following acetohexamide administration. Report of two cases with impaired renal function

1 reference

12 December 2020

Inhibition of drug metabolism by chloramphenicol

1 reference

12 December 2020

SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS

1 reference

12 December 2020

Determination of serum tolbutamide and chlorpropamide by high-performance liquid chromatography

1 reference

12 December 2020

Simple, rapid and micro high-pressure liquid chromatographic method for the simultaneous determination of tolbutamide and carboxy tolbutamide in plasma

1 reference

12 December 2020

Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)

1 reference

12 December 2020

Pharmacokinetics and biotransformation of chlorpropamide in man

1 reference

12 December 2020

Radioimmunoassay of Glibenclamide

1 reference

12 December 2020

Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects

1 reference

12 December 2020

Gas Chromatographic Method for Determination of Tolbutamide and Chlorpropamide

1 reference

12 December 2020

Metabolism and Kinetics of the Hypoglycemic Agent Glipizide in Man—Comparison with Glibenclamide

1 reference

12 December 2020

Pharmacogenetics of tolbutamide metabolism in humans

1 reference

12 December 2020

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

1 reference

12 December 2020

Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets

1 reference

12 December 2020

The bioavailability in man of marketed brands of chlorpropamide

1 reference

12 December 2020

Failure of probenecid to inhibit the rate of metabolism of tolbutamide in man

1 reference

12 December 2020

Determination of serum tolbutamide by gas chromatography

1 reference

12 December 2020

Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection

1 reference

12 December 2020

Interactions of sulfonylureas with plasma proteins.

1 reference

12 December 2020

Failure of Induction of Liver Microsomal Enzymes by Tolbutamide in Maturity-Onset Diabetics

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (second of two parts).

1 reference

12 December 2020

The binding of sulphonylureas to serum albumin

1 reference

12 December 2020

Potentiation of the hypoglycemic effect of sulfonylurea derivatives by drugs. II. Pharmacokinetics and metabolism of glibenclamide (HB 419) in presence of phenylbutazone

1 reference

12 December 2020

Severe hypoglycemia reactions following treatment with tolbutamide, carbutamide and chlorpropamide (report on 14 cases, studies on clinical symptoms and pathogenesis)

1 reference

12 December 2020

Drug Interactions with Oral Sulphonylurea Hypoglycaemic Drugs

1 reference

12 December 2020

Determination of tolbutamide and chlorpropamide in biological fluids

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics as well as metabolism following orally and intravenously administered C14-glipizide, a new antidiabetic

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (first of two parts).

1 reference

12 December 2020

Bioavailability of chlorpropamide

1 reference

12 December 2020

Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma

1 reference

12 December 2020

Enhanced response to tolbutamide in uremia

1 reference

12 December 2020

Kinetics of carboxytolbutamide excretion following tolbutamide and carboxytolbutamide administration

1 reference

12 December 2020

A method for determining 1-butyl-3-p-tolylsulphonylurea (tolbutamide) in human blood serum

1 reference

12 December 2020

Determination of plasma levels of tolbutamide (1-butyl-3-p-tolylsulfonylurea, orinase)

1 reference

12 December 2020

Pharmacokinetics of glibornuride

1 reference

12 December 2020

[Pharmacokinetics and metabolite spectrum of glisoxepide in humans]

1 reference

12 December 2020

A comparison of the acute hypoglycemic potencies of tolbutamide and chlorpropamide

1 reference

12 December 2020

Metabolism, Blood Levels and Rate of Excretion of Acetohexamide in Human Subjects

1 reference

12 December 2020

Binding of sulfonylureas to serum albumin: a response.

1 reference

12 December 2020

Determination of carboxytolbutamide in urine

1 reference

12 December 2020

Interaction of glipizide with human serum albumin

1 reference

12 December 2020

Protein interactions of sulfonylurea compounds

1 reference

12 December 2020

Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs

1 reference

12 December 2020

Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects

1 reference

12 December 2020

Pharmacokinetics and metabolism of N-(4-( -(5-methylpyrazine-2-carboxyamido)-ethyl)-benzensulfonyl)-N'cyclohexylurea (K 4024) in experimental animals and in man

1 reference

12 December 2020

Gas chromatographic determination of glibenclamide in plasma

1 reference

12 December 2020

Mechanism of glucose-induced insulin secretion

1 reference

12 December 2020

The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study

1 reference

12 December 2020

Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy

1 reference

12 December 2020

GLC determination of plasma levels of intact chlorpropamide or tolbutamide

1 reference

12 December 2020

What Patients with Diabetes Want to Know about their Therapy

1 reference

12 December 2020

Metabolic studies of chlorpropamide in normal men and in diabetic subjects

1 reference

12 December 2020

Glipizide: a review of its pharmacological properties and therapeutic use.

1 reference

12 December 2020

Pharmacokinetics of glipizide in man: Influence of renal insufficiency

1 reference

12 December 2020

Plasma concentrations, bioavailability and dissolution of chlorpropamide

1 reference

12 December 2020

Influence of the Absorption Rate of Tolbutamide on the Rate of Decline of Blood Sugar Levels in Normal Humans

1 reference

12 December 2020

Metabolic half-life times, blood levels, potencies and activity patterns of metahexamide and other sulfonylurea compounds

1 reference

12 December 2020

Sulfamethizole-induced inhibition of diphenylhydantoin, tolbutamide, and warfarin metabolism

1 reference

12 December 2020

Drug Absorption, Metabolism, and Excretion. VIII. Determination of Tolbutamide and Its Metabolites in Blood and Urine

1 reference

12 December 2020

Blood glucose lowering sulfonamides with asymmetric carbon atoms.

1 reference

12 December 2020

Metabolic fate of chlorpropamide in man and in the rat

1 reference

12 December 2020

Determination of oral anti-diabetic agents in human body fluids using high-performance liquid chromatography

1 reference

12 December 2020

10.2165/00003088-198106030-00003

Identifiers

DOI

1 reference

PubMed ID

7016385

Dimensions Publication ID

19 September 2017

0 references

1 reference

PubMed ID

7016385